Valiant Laboratories Share Price Today

Valiant Laboratories shareholders approve all 18 AGM resolutions with high majority

All 18 resolutions passed at Valiant Laboratories' 5th AGM held on September 28, 2026. Santosh Vora re-appointed as MD for 5 years with 99.998% votes in favor. Material related party transactions approved by public shareholders with >99.9% support. Promoter group abstained from voting on RPTs but supported all other governance items. Registered office shift within Maharashtra approved with 99.999% majority.

Valiant Laboratories approves ₹70 lakh stake in AMPYR solar project

Valiant Laboratories approved a ₹70 lakh cash investment in AMPYR Renewable Energy. The deal secures up to 1.01% equity to access captive solar power for the Tarapur plant. Target entity reported ₹23.26 crore turnover and ₹9.99 crore net worth as on March 31, 2026. Acquisition is expected to complete within 12 months via definitive agreements.

Valiant Laboratories sends AGM notice letters to unregistered shareholders

Valiant Laboratories sent physical letters on September 3, 2026, to unregistered shareholders. Letters provide web-links to the FY26 Annual Report and 5th AGM Notice. The fifth Annual General Meeting is scheduled for September 28, 2026, at 11:30 am. Documents are accessible via the company website and stock exchange portals. Shareholders are urged to register email addresses for future communications.

Valiant Laboratories Q1 Results: Net profit jumps 422% YoY to ₹9.48 cr

Valiant Laboratories Ltd posted a strong Q1FY27 with standalone net profit jumping 422% YoY to ₹9.48 crore and revenue rising 44% to ₹74.27 crore. Consolidated net profit turned positive at ₹21.10 crore, reversing a prior-year loss, driven by robust revenue growth across the group.

Valiant Laboratories approves ₹60 crore VASPL investment

Valiant Laboratories has approved a ₹60 crore investment in its subsidiary VASPL through Optionally Convertible Redeemable Preference Shares. The Board meeting on August 10, 2026, also saw the re-appointment of Santosh Vora and Sonal Vira, and a shift of the registered office to Palghar.

Valiant Laboratories faces GST demand of ₹18 Lakhs with penalty

Valiant Laboratories received an order dated May 29, 2026, from the Office of the Joint Commissioner, CGST & C. Ex., Navi Mumbai Commissionerate, confirming a GST demand of ₹18 Lakhs and a penalty of ₹18 Lakhs. The demand relates to a Corporate Guarantee for the period April 2023 to March 2024 and includes interest under Section 50(1) of the CGST Act, 2017. While the total initial demand was ₹36 Lakhs, the adjudicating authority dropped allegations regarding ineligible Input Tax Credit on IPO expenses of ₹2.85 Crore and a turnover mismatch of ₹9.31 Crore. The company is evaluating options to file an appeal.